What is Vertex Pharmaceuticals's granted (in shares)?

Vertex Pharmaceuticals (VRTX) reported granted (in shares) of 1.8K in Q4 2025.

What does granted (in shares) mean?

The total volume of shares awarded to employees as part of compensation packages during the period.

Vertex Pharmaceuticals Granted (in shares) remained flat by 0.0% to 1.8K in Q4 2025 compared to the prior quarter.

StatementIncome Statement

SectionOther

CategoryCapital Allocation

SignalContext dependent

VolatilityModerate

First reportedQ1 2025

Last reportedQ4 2025Feb 13, 2026

Higher grant volumes indicate more aggressive equity-based incentive programs, which may lead to increased future dilution.

This metric tracks the total number of shares granted to employees and directors under various share-based compensation...

Commonly disclosed in the equity compensation or stock plan footnotes of annual reports.

Metric ID: other_share_based_compensation_arrangement_by_share_base_1fbc5c

1 years

	FY'25
Value	7K

What is Vertex Pharmaceuticals's granted (in shares)?: Vertex Pharmaceuticals (VRTX) reported granted (in shares) of 1.8K in Q4 2025.
What does granted (in shares) mean?: The total volume of shares awarded to employees as part of compensation packages during the period.